Integrated workflow BioGenex recently launched the eFISHency integrated workflow solution for FISH laboratories, signaling a strong cross-sell opportunity to labs seeking end-to-end automation and streamlined molecular pathology processes.

Immunohistochemistry expansion The company has repeatedly introduced primary IHC antibodies and related diagnostics, presenting a sales path to pathology labs expanding their IHC capabilities and seeking validated antibody panels.

miRNA and CUP focus New miRNA ISH probe kits and CUP characterization capabilities indicate demand for advanced molecular profiling and unknown primary tumor workups, ideal for clinics aiming to enhance diagnostic precision.

Global diagnostics BioGenex emphasizes automated, high-performance molecular pathology systems with premier after-sales support, creating a compelling value proposition for large hospital networks and research institutions requiring reliable service.

Strategic partnerships Active collaborations with universities, hospitals, and pharma/biotech players provide a fertile channel for co-development, trial adoption, and senior-level procurement discussions.